Article révisé par les pairs
Titre:
  • Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Auteur:Colleoni, Marco Angelo; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair M; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seamus; Di Lauro, Vincenzo; Gombos, Andrea; Ruhstaller, Thomas; Burstein, Harold; Ribi, Karin; Bernhard, Jürg; Viale, Giuseppe; Maibach, Rudolf; Rabaglio-Poretti, Manuela; Gelber, Richard D; Coates, Alan A.S.; Di Leo, Angelo; Regan, Meredith; Goldhirsch, Aron; SOLE Investigators,
Informations sur la publication:Lancet oncology, 19, 1, page (127-138)
Statut de publication:Publié, 2018
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Aged
Antineoplastic Agents -- administration & dosage -- adverse effects
Aromatase Inhibitors -- administration & dosage -- adverse effects
Biomarkers, Tumor -- analysis
Breast Neoplasms -- chemistry -- drug therapy -- mortality -- pathology
Chemotherapy, Adjuvant
Disease-Free Survival
Drug Administration Schedule
Female
Humans
Letrozole
Middle Aged
Nitriles -- administration & dosage -- adverse effects
Postmenopause
Receptor, ErbB-2 -- analysis
Receptors, Estrogen -- analysis
Receptors, Progesterone -- analysis
Time Factors
Treatment Outcome
Triazoles -- administration & dosage -- adverse effects
Langue:Anglais
Identificateurs:urn:issn:1470-2045
info:doi/10.1016/S1470-2045(17)30715-5
info:pii/S1470-2045(17)30715-5
info:pmid/29158011

Documents en relation

DI-fusion

  • Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy
    par Jerusalem, Guy , Farah, Subrina , Courtois, A. , Chirgwin, Jacquie , Aebi, Stefan , Karlsson, Per , Neven, Patrick , Hitre, Erika , Graas, Marie-Pascale , Simoncini, Edda , Abdi, Ehtesham , Kamby, Claus , Thompson, Alastair , Loibl, Sibylle , Gavila, Joaquín , Kuroi, Katsumasa , Marth, Christian , Müller, Berit Maria B. , O'Reilly, Séamus , Gombos, Andrea , Ruhstaller, Thomas , Burstein, Harold H.J. , Rabaglio, Manuela , Ruepp, Barbara , Ribi, Karin , Viale, Giuseppe , Gelber, Richard , Coates, Alan A.S. , Loi, Sherene , Goldhirsch, Aron , Regan, Meredith , Colleoni, Marco Angelo
    Publication 2021-10
  • Genomic aberrations and late recurrence in postmenopausal women with hormone receptor⇓positive early breast cancer: results from the SOLE trial
    par Guerini-Rocco, Elena , Gray, Kathryn , Fumagalli, Caterina , Reforgiato, Marta Rita , Leone, Isabella , Raviele, Paola Rafaniello , Munzone, Elisabetta , Kammler, Roswitha , Neven, Patrick , Hitre, Erika , Jerusalem, Guy , Simoncini, Edda , Gombos, Andrea , Deleu, Ines , Karlsson, Per , Aebi, Stefan , Chirgwin, Jacquie , Lauro, Vincenzo Di , Thompson, Alastair , Graas, Marie-Pascale , Barber, Matthew , Fontaine, Christel , Loibl, Sibylle , Gavila, Joaquín , Kuroi, Katsumasa , Muller, Bettina , O’Reilly, Seamus , Leo, Angelo Di , Goldhirsch, Aron , Viale, Giuseppe , Barberis, Massimo , Regan, Meredith M.M. , Colleoni, Marco Angelo
    Publication 2021-01
  • Differential benefit of metronomic chemotherapy among triple negative breast cancer subtypes treated in the IBCSG Trial 22-00.
    par Joaquin Garcia, Andrea , Rediti, Mattia , Venet, David , Majjaj, Samira , Kammler, Roswitha , Munzone, Elisabetta , Gianni, Lorenzo , Thürlimann, Beat , Láng, I , Colleoni, Marco Angelo , Loi, Sherene , Viale, Giuseppe , Regan, Meredith M , Buisseret, Laurence , Rothé, Françoise , Sotiriou, Christos
    Publication 2023-09-01
  • Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
    par Partridge, Ann H , Niman, Samuel M , Ruggeri, Monica , Peccatori, Fedro Alessandro , Azim, Hatem A , Colleoni, Marco Angelo , Saura, Cristina , Shimizu, Chikako , Sætersdal, Anna Barbro , Kroep, Judith R , Mailliez, Audrey , Warner, Ellen , Borges, Virginia F , Amant, Frédéric , Gombos, Andrea , Kataoka, Akemi , Rousset-Jablonski, Christine , Borstnar, Simona , Takei, Junko , Lee, Jeong E , Walshe, Janice M , Ruíz-Borrego, Manuel , Moore, Halle C F , Saunders, Christobel , Bjelic-Radisic, Vesna , Susnjar, Snezana , Cardoso, Fatima , Smith, Karen L , Ferreiro, Teresa , Ribi, Karin , Ruddy, Kathryn , Kammler, Roswitha , El-Abed, Sarra , Viale, Giuseppe , Piccart-Gebhart, Martine , Korde, Larissa A , Goldhirsch, Aron , Gelber, Richard D , Pagani, Olivia , International Breast Cancer Study Group , POSITIVE Trial Collaborators
    Publication 2023-05
  • Luminal breast cancer: clinical and translational aspects of resistance to m-Tor inhibitors
    par Gombos, Andrea
    Publication Faculté de Médecine – Sciences médicales, Bruxelles, Université libre de Bruxelles, 2023-03-16